bpc 157 clinical trial human study bpc-157 dosage for humans studies typical use dose microgram as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers BPC-157 Dosing (Common Daily Optimization

Reconstitution Solution for Laboratory Use

RCC, retrospective case control

Daily Optimization

Size:20mg Pre-Filled Pen (SubQ)

Available Strengths: 10mg total — 5mg BPC-157 + 5mg TB-500 20mg total — 10mg BPC-157 + 10mg TB-500 Product Specifications Product Name: BPC-157 / TB-500 Blend Peptide Product Contents: BPC-157 / TB-500 lyophilized powder blend in a 3mL glass vial Available Strengths: 10mg total, 20mg total Blend Composition: 10mg vial — 5mg BPC-157 + 5mg TB-500 20mg vial — 10mg BPC-157 + 10mg TB-500 Bulk Savings: Save 20% when you order 4+ vials and 25% on 8+ vials (discount applied automatically in cart) Peptide Type: Synthetic BPC-157 pentadecapeptide combined with a synthetic thymosin beta-4-derived peptide blend Purity: 99% — third-party tested using HPLC-MS Molecular Formula: BPC-157: C62H98N16O22 TB-500: C212H350N56O78S Molecular Weight: BPC-157: 1419.56 g/mol TB-500: 4963.44 g/mol Amino Acid Sequence: BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser CAS Number: BPC-157: 137525-51-0 TB-500: 77591-33-4 PubChem CID: BPC-157: 9941957 TB-500: 16132341 Synonyms: BPC-157 / TB-500 Blend, Body Protection Compound 157 / Thymosin Beta-4 Appearance: White to off-white lyophilized powder in a glass vial Solubility: Soluble in water Storage: Store at ≤6°C in a sealed container, protected from heat, light, and moisture